New sedative may make lung exams safer and smoother

NCT ID NCT07184801

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether dexmedetomidine, a sedative, works better than midazolam for keeping patients comfortable during medical thoracoscopy—a procedure where doctors look inside the chest cavity. About 56 adults with unexplained fluid around the lungs will be randomly assigned to receive one of the two drugs. The goal is to see if dexmedetomidine reduces the need for extra pain medicine, shortens recovery time, and lowers the risk of complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Dexmedetomidine (a sedative drug)

What this could lead to

If it works, this could point toward a better sedation option for lung procedures, making them safer and more comfortable for patients.

What could go wrong

This is a small, early-phase trial with only 56 participants, so results may not apply to everyone. Both drugs have known side effects like low blood pressure or slow heart rate.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MEDICAL THORACOSCOPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Bronchoscopy suite

    RECRUITING

    Chandigarh, Chandigarh, 160012, India

    Contact Phone: •••-•••-•••• Email: •••••@•••••